Favipiravir May be an Effective COVID-19 Treatment
November 25, 2020 09:00pm
By Sara Karlovitch, Assistant Editor
The CDC is making strides toward better understanding the pneumonia-like coronavirus (2019-nCoV) that originated in Wuhan, China.
The CDC has announced a second confirmed case of the world's new coronavirus in the United States, this time in Chicago. Officials said the patient, a woman aged in her 60s, is in stable condition, although she remains isolated in the hospital as a precaution.
On Tuesday, the CDC announced that the first US case was confirmed in Washington State.
The CDC is making strides toward better understanding the pneumonia-like coronavirus (2019-nCoV) that originated in Wuhan, China, including sequencing the entire genome, and growing the virus in cell culture.
the virus has resulted in 26 deaths, and 830 infections in China, as of January 24.
Chinese authorities have expanded a travel lockdown in the country to include nearly 35 million residents, banning any public transport in or out of the region.
The New York Times,
The virus is especially concerning because of its person-to-person spread, which can happen on a continuum, according to the CDC.
Patients confirmed to have the virus have reportedly experienced mild to severe respiratory illness, including fever, cough, and shortness of breath. The CDC currently believes that symptoms may appear between 2 and 14 days after exposure, based on the incubation period of previous coronaviruses, such as MERS (Middle Eastern Respiratory Syndrome).
Read the full article onPharmacy Times.